Summary.-C3Hf/Dp;-mice were given a single i.p. injection of 50, 25 or 5 ,ug/g N-Nitroso-N-Methylurea (NMU) at either I or 70 days of age or 50 flg/g at 21 days of age. They were olbserved until death or until 120 weeks of age.
at 1 day. In'the other groups the' incidence of thymic lymphomata was zero or negligible. The rate of progression of thymic lymphomata until death was related to both earliness of treatment and dose. On the contrary, incidences and progression of carcinomata of the forestomach were unrelated to age at treatment. Since breakdown of NMU is very rapid and does not require enzymes, these results are considered as evidence that host-tumour interaction differs from organ to organ.
No excess of tumours over the controls was found in mice receiving 5 ,ug/g either at 1 or 70 days of age.
THE CARCINOGENIdITY of N-nitroso-N-methylurea (NMU) in different species of laboratory animals i § well"estab-lished (IARC, 1972) . A single adminiAtration of this chemical 'can induice'a high yield of tumours at diff4rent sites in mice and rats (Druckrey et al., 1964; :Graffi and Hoffmann, 1966; -Terracini and Stramignoni, 1967; Kelly et al., 196''; ' Leaver, Swann and Magee, 1969-; Frei, 1970; Joshi and Frei, 1970; Terracini arid Testa, 1970; Frei, 1971) . NMU-is' also known to undergo rapid deconmposition at physiological pH (Druckrey et 'al., 1967; Swann, 1968 19y? and 20,-3) . Results for these additional groups are not included in the tables and figures as they did not differ from those observed among controls. Mice treated at 1 or 21 days of age were left with their mothers until weaning, which occurred at 25-28 days of age. At weaning, a few animals from some groups were used for purposes outside the present report. Also 3 mice from the control group were lost during the experiment. All other mice were allowed to die naturally or were killed with ether when moribund or if they survived to 120 weeks of age. Mice were examined daily and weighed at weekly intervals until 10 weeks of age and then at fortnightly intervals.
All mice were submitted to autopsy including opening of the skull but not of the spinal cord. The thymus, liver, kidneys, spleen and orbital glands as well as any organs showing gross abnormalities were fixed in Bouin's fluid and histologically examined in sections stained with haematoxylin and eosin.
Cumulative probabilities of dying with tumours at any site, thyhic lymphomata or carcinomata of the forestomach have been calculated according to the formula:
where Pn represents the probability of having died with that event by the end of week n, N is the number of animals alive at the beginning of each week and t is the number of animals dying with that event during each week (Saffiotti et al., 1972 Distribution of deaths vs. time in the whole population of mice under study is represented in Fig. 1 Age ( Dose-related differences in cumulative probabilities of dying with tumours at any age are far more obvious (Fig. 4) produce an obvious increase over the controls in the probability of dying with a tumour at any site.
Tumours of the forestomach Of 87 mice with tumours of the forestomach, 42 had at least one carcinoma of the forestomach and the other 45 had one or more papillomata (Table II) . A sizeable incidence of carcinomata of the forestomach was found in Groups V and VI, receiving 50 ,tg/g NMU at 21 and 70 days of age respectively. Fig. 5 represents the distribution of the cumulative probability of dying with a carcinoma of the forestomach in these two groups: when time since treatment is considered, the two lines are almost overlapping, indicating that the two treatments were equally effective. Average time elapsing between treatment and death with car- 46 and 64 weeks after treatment), and 8 had one or multiple papillomata of the forestomach. The overall incidence of 10/40 mice developing stomach tumours was higher than that of 5/59 found in the controls (P < 0.05). Among mice receiving 5 ,tg/g NMU at 1 or 70 days of age the incidence of stomach papillomata was, if anything, lower than in the controls.
Other tumours
Target organs of the carcinogen NMU included lungs, liver, kidney, intestine, ovary, uterus and vagina (Table II) . The incidences of some of these tumours among survivors at 40 weeks of age are reported in Table IV. A significant increase (P < 0.01) of the proportion of mice dying with lung adenomata was found in both sexes in (Graffi and Hoffmann, 1966; Terracini and Stramignoni, 1967; Kelly et al., 1968; Frei, 1970; Joshi and Frei, 1970; Terracini and Testa, 1970; Frei, 1971) . The sporadic occurrence of neurogenic tumours in the present series as well as in previous studies differs from findings following a single administration of the related compound N-nitroso-N-ethylurea (Searle and Jones, 1972; Vesselinovitch et al., 1974) .
Reviews on the role of age at treatment in chemical carcinogenesis lead to the conclusion that neonates are more susceptible than older animals to the induction of lymphomata, liver-cell tumours and lung adenomata, whereas results for other target organs are less definite (Toth, 1968; Della Porta and Terracini, 1969 (Toth, 1968; Della Porta and Terracini, 1969) .
The progressive decrease of the susceptibility to thymic lymphoma induction from birth to 10 weeks of age confirms previous studies with NMU itself (Terracini and Testa, 1970) , urethane (De Benedictis et al., 1964; Vesselinovitch, Mihailovich and Itze, 1970) , DMBA (Toth, Rappaport and Shubik, 1961) and Nnitroquinoline-1-oxide (Nishizuka, Nakakuki and Sakakura, 1964). In one of such studies, (C57BL x C3H)F1 mice aged 25 weeks were found completely resistant to treatment with urethane at a dose which was highly active in newborn mice (Vesselinovitch et al., 1970) .
On the other hand, when a comparison is made between groups of the carcinogenic action on all organs excluding the thymus, age at treatment seemed to play a minor role. Analyses of tumour incidences in individual organs is limited by interference caused by intercurrent deaths. However, hepatocarcinogenicity was confined to male mice receiving 25 or 50 ,ug/g NMU at 1 or 21 days of age. In a previous study on the same colony of C3Hf/Dp mice, a single administration of 1 mg urethane at birth was equally effective on both sexes (Della Porta et al., 1967) .
The susceptibility to carcinogenesis of the ovary and orbital glands seems to be lower in newborns than in animals aged 21 or 70 days, in confirmation of previous studies with urethane and Nnitroso-N-ethylurea (Vesselinovitch and Mihailovich, 1967; Vesselinovitch et al., 1974) .
In the present series, the probability of dying with a carcinoma of the forestomach following 50 ,tg/g was the same in mice treated at 21 days and in those treated at 70 days of age. Among animals given 25 ,tg/g NMU, the proportion developing benign or malignant tumours of the forestomach was 12/41 in those treated at birth and 10/40 in those treated at 70 days of age. Although 6 of the former had a carcinoma vs. 2 of the latter, these differences are hardly significant. In a previous study with 437 N-nitroso-N-ethylurea, mice treated at birth were slightly less susceptible to stomach carcinogenesis than those treated at 15 or 42 days of age (Vesselinovitch et al., 1974) .
Lifetime analysis in the present series indicates that lymphomata following exposure to 50 ,ug/g NMU at birth not only are more frequent but also progress to death more rapidly than those induced later in life. By and large this is confirmatory of previous investigations with NWU (Terracini and Testa, 1970) , DMBA (Toth et al., 1961) and urethane (De Benedictis et al., 1964) as well as with Gross' passage A virus (Axelrad and Van der Gaag, 1962) .
The difference in the mechanism of carcinogenesis reflected in this result might take place either at the time of the interaction between carcinogen and cell components or during tumour development. It is unlikely that age at treatment affects the persistence in the target organ of NMU, as this is an unstable compound, rapidly broken down without enzymic activation (Druckrey et al., 1967; Swann, 1968) . Morphological differences of the thymus between newborn and adult mice (Axelrad and Van der Gaag, 1962) do not appear to be involved, since thymic lymphomata induced in newborn mice with low doses of NMU progressed relatively slowly. In addition, no morphological differences were found between lymphomata occurring in mice treated at birth and those found in mice treated later in life.
The different rate of progression of thymic lymphomata related to age at treatment more likely reflects differences in tumour-host relationships during the early phases of tumour development. " Natural " age-related differences such as immunosurveillance and the hormonal situation do not seem to be relevant since thymic lymphomata induced by a low dose of NMU at birth progressed as slowly as those induced by a high dose given at 10 weeks of age.
On the other hand, an age-related systemic effect of NMU on the general status of the animals is reflected in the degree of body growth inhibition related to age at treatment. A role of NMUinduced immuno-depression is possible, but the impact of age at treatment on this effect has not been investigated (Parmiani, Colnaghi and Della Porta, 1971 ). This hypothesis is compatible with the theory that chemical induction of lymphomata in mice is mediated by viral activation (Kaplan, 1967) .
Age-related factor(s) affecting tumourhost relationship do not appear to be involved in the mechanism of carcinogenesis for the stomach, where progression was independent of age at treatment. This discrepancy between thymic lymphomata and carcinomata of the forestomach is reminiscent of a previous observation that the immunological status of NMUtreated rats does not affect equally the induction of tumours of the nervous system and that of tumours of the bladder (Denlinger et al., 1973) . This again suggests that host-tumour interaction may be quite different according to the organs involved.
